Navigation Links
UK company to demonstrate their commercially effective graphene production process
Date:4/6/2012

Haydale, a wholly owned subsidiary of British company Innovative Carbon Limited today announces that they will be exhibiting at Graphene 2012 from 10th April to 13th.

Graphene, a sheet of carbon just one atom thick, has been described as the new wonder material. First isolated at Manchester University in 2004, for which the team was awarded a Nobel Prize, the race has been on to produce it commercially. To support this work the UK Government recently announced a 50m investment into developing a research and technology hub to explore the commercialisation of Graphene. Similarly the EU has pledged 100m annually for the next 10 years looking at the exploitation of Graphene in Information and Communication Technology (ICT) and consumer applications.

The major players in this industry will be coming together at an international conference in Brussels next week. Haydale, based in South Wales and with close ties to leading UK Universities will be part of the British contingent. Their unique patented plasma based technology, which is winning plaudits around the world, enables the scaleable production of Graphene Nano Platelets (GNPs) from powdered graphite. The process can now produce commercial quantities of a consistently high quality in an economic and environmentally friendly way.

There are a vast array of applications for Graphene, but in Brussels Haydale will be displaying a range of current offerings produced via their novel patented process, including a transparent conductive membrane that could be a competitor of Indium Tin Oxide (one of the key components in photovoltaic cells and touch screen devices); graphene loaded polymer pellets; samples of GNPs and a conductive ink, capable of replacing some silver based products. The ink has many applications and could positively impact on the radio frequency identification and security industry. Haydale will have their scientists and engineers at the show to discuss these and other potential applications and to explain their split plasma process and the characterisation capability of the technology.

Haydale has now started to offer a range of GNPs and other materials to the open market under the brand HDPlas.

Critically, organisations can now use the HDPlas product range for product prototyping and analysis. Haydale offers expertise in running pilot trials to evaluate the effect their GNPs have on the client's materials and products and crucially assessing their suitability for large scale production. The key to take up is to know that commercial quantities are then available.

Haydale, who are moving to new purpose built state of the art facilities in South Wales, is now able to supply HDPlas from stock as well as to order. A technical analysis sheet, which includes typical characterisation data and representational images, has been prepared and will accompany the goods so that the buyer can instantly see the product specification without needing to spend valuable time and resource in independent verification procedures.

Commenting, Chairman Tony Belisario said:

"We are all very excited by the opportunity our patented process offers as a critical element of material replacement for enhanced performance of a vast array of potential applications. The market is looking for ways of using the new wonder material Graphene and we believe that we have the process that can now make the commercial quantities required by global companies. The cutting edge technology has been peer reviewed and we can now do "what it says on the tin". We have proved we can personalise solutions to a clients specific needs in a cost effective, environmentally friendly and innovative way. Graphene 2012 is a perfect place to launch our technology and we expect significant interest in Haydale."


'/>"/>

Contact: Trevor Phillips
trevor.phillips@hermesfinancialpr.co.uk
44-788-915-3628
Hermes Financial Public Relations
Source:Eurekalert

Related biology technology :

1. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
2. Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
3. Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
5. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
6. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
7. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
8. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
9. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
10. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
11. Monsanto Declared Worst Company of 2011 by NaturalSociety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  Allergan plc (NYSE: ... announced that Brent Saunders , Allergan,s CEO and ... a fireside chat session at the RBC Capital Markets ... p.m. ET at The New York Palace Hotel in ... will be webcast live and can be accessed on ...
(Date:2/10/2016)... ... 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused ... latest InGaAs PIN diode standard packages feature a TO-46 metal can with active areas ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) ... the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies. ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 Technology ... service presents an analysis of the digital and computed ... Malaysia , and Indonesia ... current trends and market size, as well as regional ... by country and discusses market penetration and market attractiveness, ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
Breaking Biology News(10 mins):